VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,940,000 | +76.0% | 121,483 | +59.9% | 1.19% | +85.8% |
| Q3 2021 | $2,239,000 | -27.6% | 75,983 | -16.5% | 0.64% | -19.8% |
| Q2 2021 | $3,092,000 | -11.9% | 90,983 | -15.7% | 0.80% | -13.3% |
| Q1 2021 | $3,509,000 | -12.2% | 107,983 | -2.7% | 0.92% | -8.7% |
| Q4 2020 | $3,998,000 | +7.5% | 110,983 | +16.8% | 1.01% | -4.4% |
| Q3 2020 | $3,720,000 | -3.4% | 94,983 | -9.5% | 1.06% | -16.9% |
| Q2 2020 | $3,851,000 | +66.5% | 104,983 | +4.6% | 1.27% | +54.3% |
| Q1 2020 | $2,313,000 | +61.0% | 100,365 | +104.6% | 0.82% | +114.9% |
| Q4 2019 | $1,437,000 | +9.8% | 49,065 | +141.8% | 0.38% | +19.3% |
| Q3 2019 | $1,309,000 | +13.8% | 20,290 | -54.9% | 0.32% | +3.2% |
| Q2 2019 | $1,150,000 | -12.2% | 45,000 | -22.8% | 0.31% | -11.4% |
| Q1 2019 | $1,310,000 | +38.0% | 58,300 | +29.6% | 0.35% | +16.6% |
| Q4 2018 | $949,000 | – | 45,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |